Role of Consultants & Clients

in the development of Clinical Evaluation Report for Medical Device

I3CGLOBAL achieves positive results using the proven process for medical device clinical evaluation documentation. We are meticulous about the CER preparation methodology, so we place more emphasis on customer support in order to achieve quality and faster submissions to NB in lesser man-days and therefore overall costs for our customers. With the support of the client team and our advisors, here’s how we divided the scope of I3CGLOBAL and Client.

	DOCUMENTATION	SCOPE OF WORK (I3CGlobal)	SCOPE OF WORK (Client)
STAGE 0	0.1 Clinical Evaluation Procedure	Development of Quality System Procedure(s) (QSP), SOPs and templates as per CLIENT MDQMS /GMP relevant for MDR documentation related to Clinical Evaluation Clinical Evaluation Planning DOI and CV template	Requires input for current stage of Clinical Development of the device Requires documentation numbering according to the control of documents of CLIENT QMS system
	0.2 SOP for Clinical Evaluation Plan
	0.3 Clinical Evaluation Plan
	0.4 Draft of Declaration of Interest (DOI)
	0.5 CV of the Evaluator

STAGE 1	1.1 SOP for Identification of Pertinent Data	Formats SOPs and templates as per CLIENT MDQMS /GMP Identifies data that can be retrieved from CLIENT and adds data based on that to the template Plans the literature search based on the keywords as per the PICO Performs a systematic and comprehensive literature search from scientific databases based on research questions to meet the requirements of Annex I, MDR [GSPR] Prepares the literature search report for meeting the requirement of safety and performance of the device	Information of pre-clinical studies and non-clinical studies Information of any clinical studies such Clinical investigations as ISO 14155 or Post-market studies on the device as per I3C team request
	1.2 Data Retrieved from the Manufacturer
	1.3 SOP for Literature Search and Review
	1.4 Literature Search and Review Plan
	1.5 Literature Search and Review Report

STAGE 2	2.1 SOP for Demonstration of Equivalence	Formats SOPs and templates as per CLIENT MDQMS /GMP Performs demonstration of equivalence (if a contract has been signed between your company and the manufacturer of equivalent device) Informs about similar device details obtained from literatures (if any) Appraises the clinical data collected from the CLIENT as well as that from the literature search	Contract between CLIENT and equivalent device manufacturer (if applicable) Identification of equivalent device and provide the details for demonstration of equivalence (if claiming the equivalency)
	2.2 Demonstration of Equivalent Devices
	2.3 SOP for Appraisal of Clinical Data
	2.4 Clinical Data Appraisal Plan
	2.5 Appraisal of Pertinent Data
STAGE 3	3.1 SOP for Analysis of the Clinical Data	Formats SOPs and templates as per CLIENT MDQMS /GMP Performs qualitative analysis of the clinical data obtained from the literature as well as data retrieved from CLIENT
	3.2 Analysis of the Clinical Data

STAGE 4	4.1 SOP for Development of CER	Formats QSP, SOPs and templates as per CLIENT MDQMS/GMP Creates the CER based on the summary of inputs from clinical data from CLIENT and the literatures from stage 1 meeting the GSPR Reviews, guides and makes necessary modification on CLIENT RMF PSUR and PMCF plan and reports For PMS – Data collection and analysis based on the reactive and proactive sources selected by CLIENT, Preparation of PMS report with CLIENT’s support For PMCF – Supports in selection of the model or variant for the study, Prepares PMCF Evaluation Report For initial PSUR- Benefit-risk determination and conclusion Suggests changes in the IFU based on the inputs from the CER, RMF, PSUR, PMS/PMCF	Provide documents such as previously submitted CER, RMFs, PMS/PMCF and the IFU or the user guide/manual For PMS – PMS planning, Customer feedback reports of the specified time period, Complaint records, CAPA reports, Information of Sales history, Sales volume or any other supportive evidences based on the sources selected for PMS For PMCF study – PMCF planning, selection of PMCF study based on I3C inputs, selection of study centers, appointment of Clinical investigator(s), Analysis and study conclusion For initial PSUR- Acceptability of benefit-risk profile, Information of usage frequency of the device Approvals in all the documents prepared by I3C
	4.2 Clinical Evaluation Report with below supporting evidences
	4.2(a) Risk Analysis procedure + Risk Management File
	4.2(b) Post Market Surveillance (PMS) procedure + Records Templets + PMS Plan + PMS records (Client must organize as per our guidance)
	4.2(c) Post Market Clinical Follow-up (PMCF) procedure + Records Templets + PMCF records (Client must organize as per our guidance)
	4.2(d) Periodic Safety Update Report (PSUR)
	4.2(e) IFU

I3C SCOPE (General)

CLIENT SCOPE (General)

Maintains data security and privacy for all documents generated on behalf of CLIENT also for the documents provided by CLIENT
Maintains safety & security of the files in cloud DROPBOX
Assures Virus protection
Weekly Project status update on Fridays.
Weekly email communication status update on Fridays
Maintain on-time delivery of documents as per CLIENT instruction and initial agreement.

At least one core technical person must interact with I3C team for the first TWO months of project initiation.
CLIENT technical team should have DROPBOX access
Access to Skype, WhatsApp, Email, Mobile for communication.
CLIENT team must provide product scientific and technical details whenever asked by I3C team
CLIENT should coordinate with I3C team for the timely completion
CLIENT should review all documents prepared by I3C team

Language of Communication – English
Geographical Location of Technical Consultants – India
Minimum Assurance on team qualification – Postgraduates and Graduates in Microbiology, Pharmacy, Biomedical.
Minimum promise of manpower allocation is Maximum 4 Nos.
Travelling to client location by our consultants on request and planned schedule only in case of necessity. We charge $ 300/day + Accommodation and traveling cost from Bangalore, Dusseldorf or Chicago for a maximum of 2 days.

Go Back